Literature DB >> 12654795

Pneumococcal behavior and host responses during bronchopneumonia are affected differently by the cytolytic and complement-activating activities of pneumolysin.

Rania Jounblat1, Aras Kadioglu, Tim J Mitchell, Peter W Andrew.   

Abstract

Pneumolysin, a multifunctional toxin produced by all clinical isolates of Streptococcus pneumoniae, is strongly implicated in the pathogenesis of pneumococcal bronchopneumonia and septicemia. Using isogenic mutant strains, we examined the effect of deletion of the cytotoxic activity or complement-activating activity of pneumolysin on bacterial growth in lungs and blood, histological changes in infected lung tissue, and the pattern of inflammatory cell recruitment. Both of the activities of pneumolysin contributed to the pathology in the lungs, as well as the timing of the onset of bacteremia. Histological changes in the lungs were delayed after infection with either mutant compared to the changes seen after infection with the wild-type pneumococcus. The complement-activating activity of pneumolysin affected the accumulation of T cells, whereas the toxin's cytolytic activity influenced neutrophil recruitment into lung tissue.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654795      PMCID: PMC152068          DOI: 10.1128/IAI.71.4.1813-1819.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Induction of gamma interferon and nitric oxide by truncated pneumolysin that lacks pore-forming activity.

Authors:  Hisashi Baba; Ikuo Kawamura; Chikara Kohda; Takamasa Nomura; Yutaka Ito; Terumi Kimoto; Isao Watanabe; Satoshi Ichiyama; Masao Mitsuyama
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

2.  Host cellular immune response to pneumococcal lung infection in mice.

Authors:  A Kadioglu; N A Gingles; K Grattan; A Kerr; T J Mitchell; P W Andrew
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

Review 3.  Structure and function of pneumolysin, the multifunctional, thiol-activated toxin of Streptococcus pneumoniae.

Authors:  G J Boulnois; J C Paton; T J Mitchell; P W Andrew
Journal:  Mol Microbiol       Date:  1991-11       Impact factor: 3.501

4.  Activation of human complement by the pneumococcal toxin pneumolysin.

Authors:  J C Paton; B Rowan-Kelly; A Ferrante
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

5.  Inhibition of human polymorphonuclear leukocyte respiratory burst, bactericidal activity, and migration by pneumolysin.

Authors:  J C Paton; A Ferrante
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

6.  Role of inflammatory mediators in resistance and susceptibility to pneumococcal infection.

Authors:  Alison R Kerr; June J Irvine; Jennifer J Search; Neill A Gingles; Aras Kadioglu; Peter W Andrew; William L McPheat; Charles G Booth; Tim J Mitchell
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

7.  Inhibition of in vitro human lymphocyte response by the pneumococcal toxin pneumolysin.

Authors:  A Ferrante; B Rowan-Kelly; J C Paton
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

8.  Complement activation and antibody binding by pneumolysin via a region of the toxin homologous to a human acute-phase protein.

Authors:  T J Mitchell; P W Andrew; F K Saunders; A N Smith; G J Boulnois
Journal:  Mol Microbiol       Date:  1991-08       Impact factor: 3.501

9.  Pneumolysin stimulates production of tumor necrosis factor alpha and interleukin-1 beta by human mononuclear phagocytes.

Authors:  S Houldsworth; P W Andrew; T J Mitchell
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

Review 10.  Molecular analysis of the pathogenicity of Streptococcus pneumoniae: the role of pneumococcal proteins.

Authors:  J C Paton; P W Andrew; G J Boulnois; T J Mitchell
Journal:  Annu Rev Microbiol       Date:  1993       Impact factor: 15.500

View more
  27 in total

1.  CD4-T-lymphocyte interactions with pneumolysin and pneumococci suggest a crucial protective role in the host response to pneumococcal infection.

Authors:  Aras Kadioglu; William Coward; M Joseph Colston; Colin R A Hewitt; Peter W Andrew
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

2.  Immunization with pneumolysin protects against both retinal and global damage caused by Streptococcus pneumoniae endophthalmitis.

Authors:  Melissa E Sanders; Erin W Norcross; Quincy C Moore; Jonathan Fratkin; Hilary Thompson; Mary E Marquart
Journal:  J Ocul Pharmacol Ther       Date:  2010-10-29       Impact factor: 2.671

Review 3.  Cholesterol-dependent cytolysins, a family of versatile pore-forming toxins.

Authors:  Rodney K Tweten
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

Review 4.  Role of pore-forming toxins in bacterial infectious diseases.

Authors:  Ferdinand C O Los; Tara M Randis; Raffi V Aroian; Adam J Ratner
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

5.  THP-1 monocytes up-regulate intercellular adhesion molecule 1 in response to pneumolysin from Streptococcus pneumoniae.

Authors:  Justin Thornton; Larry S McDaniel
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

6.  The apoptotic response to pneumolysin is Toll-like receptor 4 dependent and protects against pneumococcal disease.

Authors:  Amit Srivastava; Philipp Henneke; Alberto Visintin; Sarah C Morse; Victoria Martin; Claire Watkins; James C Paton; Michael R Wessels; Douglas T Golenbock; Richard Malley
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

7.  Pneumolysin-mediated activation of NFkappaB in human neutrophils is antagonized by docosahexaenoic acid.

Authors:  H Fickl; R Cockeran; H C Steel; C Feldman; G Cowan; T J Mitchell; R Anderson
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

8.  PavA of Streptococcus pneumoniae modulates adherence, invasion, and meningeal inflammation.

Authors:  Daniela Pracht; Christine Elm; Joachim Gerber; Simone Bergmann; Manfred Rohde; Marleen Seiler; Kwang S Kim; Howard F Jenkinson; Roland Nau; Sven Hammerschmidt
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

Review 9.  Animal models of Streptococcus pneumoniae disease.

Authors:  Damiana Chiavolini; Gianni Pozzi; Susanna Ricci
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

10.  Pneumolysin is a key factor in misidentification of macrolide-resistant Streptococcus pneumoniae and is a putative virulence factor of S. mitis and other streptococci.

Authors:  Chris Neeleman; Corné H W Klaassen; Debbie M Klomberg; Hanneke A de Valk; Johan W Mouton
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.